941 related articles for article (PubMed ID: 19023262)
1. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
[TBL] [Abstract][Full Text] [Related]
2. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Dec; 56(50):1318-20. PubMed ID: 18097345
[TBL] [Abstract][Full Text] [Related]
3. Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(3):58-60. PubMed ID: 19177041
[TBL] [Abstract][Full Text] [Related]
4. Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):673-4. PubMed ID: 19553904
[TBL] [Abstract][Full Text] [Related]
5. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine.
Bender JM; Cox CM; Mottice S; She RC; Korgenski K; Daly JA; Pavia AT
Clin Infect Dis; 2010 Apr; 50(7):e41-6. PubMed ID: 20178414
[TBL] [Abstract][Full Text] [Related]
6. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(11):234-7. PubMed ID: 11925021
[TBL] [Abstract][Full Text] [Related]
7. Knowledge of interim recommendations and use of Hib vaccine during vaccine shortages.
Kempe A; Babbel C; Wallace GS; Stokley S; Daley MF; Crane LA; Beaty B; Black SR; Barrow J; Dickinson LM
Pediatrics; 2010 May; 125(5):914-20. PubMed ID: 20403935
[TBL] [Abstract][Full Text] [Related]
8. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):901-6. PubMed ID: 8927012
[TBL] [Abstract][Full Text] [Related]
9. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
[TBL] [Abstract][Full Text] [Related]
10. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1993-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(29):545-50. PubMed ID: 7616949
[TBL] [Abstract][Full Text] [Related]
11. Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(33):1069-72. PubMed ID: 20798669
[TBL] [Abstract][Full Text] [Related]
12. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
[TBL] [Abstract][Full Text] [Related]
13. Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(46):993-8. PubMed ID: 9843325
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
15. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease.
Bisgard KM; Kao A; Leake J; Strebel PM; Perkins BA; Wharton M
Emerg Infect Dis; 1998; 4(2):229-37. PubMed ID: 9621193
[TBL] [Abstract][Full Text] [Related]
16. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.
Adam HJ; Richardson SE; Jamieson FB; Rawte P; Low DE; Fisman DN
Vaccine; 2010 May; 28(24):4073-8. PubMed ID: 20398617
[TBL] [Abstract][Full Text] [Related]
17. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
Black SB; Shinefield HR
Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
[TBL] [Abstract][Full Text] [Related]
18. [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].
Conyn-van Spaendonck MA; Veldhuijzen IK; Suijkerbuijk AW; Hirasing RA
Ned Tijdschr Geneeskd; 2000 May; 144(22):1069-73. PubMed ID: 10850110
[TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
[TBL] [Abstract][Full Text] [Related]
20. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.
von Gottberg A; Cohen C; Whitelaw A; Chhagan M; Flannery B; Cohen AL; de Gouveia L; Plessis Md; Madhi SA; Klugman KP;
Vaccine; 2012 Jan; 30(3):565-71. PubMed ID: 22119925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
